Zai Lab (ZLAB) Liabilities and Shareholders Equity (2016 - 2026)

Zai Lab (ZLAB) has reported Liabilities and Shareholders Equity for 11 consecutive years, with $1.1 billion the latest figure, recorded in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 6.61% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 billion (up 5.99% YoY) and the FY2025 annual result came in at $1.2 billion, down 1.13% from the prior year.
• Liabilities and Shareholders Equity retreated to $1.1 billion in Q1 2026 per ZLAB's latest filing, from $1.2 billion in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for ZLAB reached as high as $1.5 billion in Q1 2022 and fell as low as $985.3 million in Q3 2024.
• A 5-year average of $1.2 billion and a median of $1.2 billion in 2025 frame the typical range for Liabilities and Shareholders Equity.
• The largest YoY upside for Liabilities and Shareholders Equity was 32.67% in 2022 against a maximum downside of 25.14% in 2022.
• Year by year, Liabilities and Shareholders Equity stood at $1.2 billion in 2022, then dropped by 15.07% to $1.0 billion in 2023, then advanced by 14.42% to $1.2 billion in 2024, then decreased by 1.13% to $1.2 billion in 2025, then fell by 6.54% to $1.1 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $1.1 billion, $1.2 billion, and $1.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.